Glioblastomas are the most common form of malignant primary brain tumor and an important
cause of morbidity and mortality. In recent years there have been important advances in …

Patients with glioma present with complex palliative care needs throughout their disease
trajectory. The life-limiting nature of gliomas and the presence of specific symptoms related …

Fatigue is the most common symptom experienced by patients during the cancer trajectory
from diagnosis to the end of life and is defined as a distressing, persistent, subjective sense …

Cognitive functioning has gained greater awareness in the neuro-oncological community,
and methods to preserve and improve cognitive functioning have been explored …

Advances in cancer treatments have led to substantially improved survival for patients with
cancer. However, many patients experience changes in cognition as a side effect of both …

The late neurocognitive and psychosocial effects of treatment for pediatric brain tumor (PBT)
represent important areas of clinical focus and ongoing research. Neurocognitive sequelae …

Patients with malignant brain tumors are prone to complications that negatively impact their
quality of life and sometimes their overall survival as well. Tumors may directly provoke …

Sandra A. Mitchell, PhD, CRNP, AOCN®, is a research scientist in the Division of Cancer
Control and Population Sciences at the National Cancer Center in Bethesda, MD; Amy J …

Cognitive dysfunction is a challenging adverse effect of chemotherapy and radiotherapy that
has limited treatment options. Clinical trials for proposed pharmacotherapeutic interventions …

The potentially detrimental effects of cancer and related treatments on cognitive functioning
are emerging as a key focus of cancer survivorship research. Many patients with central …